| Antimicrobial consumption | Antimicrobial Resistance | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Neisseria gonorrhoeae | Escherichia coli | Klebsiella pneumoniae | Streptococcus pneumoniae | Acinetobacter spp. | Pseudomonas aeruginosa | ||||||||||
1997 | FD | 2018 | FD | 2009 | 2018 | 2000 | 2018 | 2005 | 2018 | 2005 | 2018 | 2005 | 2018 | 2005 | 2018 | |
N | 14 | Â | 29 | Â | 17 | 27 | 4 | 29 | 21 | 29 | 26 | 28 | 26 | 28 | 26 | 29 |
ESCephalosporin | 1.7 (0.6–4.0) | 313 | 1.9 (0.6–2.7) | 262 | 0.9 (0.0–6.4)a | 0.0 (0.0–2.2)a | 0.2 (0.1–1.9) | 13.8 (9.6–19.3) | 7.1 (4.1–27.7) | 30.8 (12.8–53.3) | NA | NA | NA | NA | NA | NA |
Fluoroquinolone | 1.0 (0.5–1.6) | 13.8 | 1.2 (0.8–2.3) | 7.0 | 70.0 (49.1–79.2) | 55.0 (44.4–60.0) | 3.8 (2.5–6.0) | 23.9 (17.7–32.1) | 11.1 (4.9–34.0) | 30.4 (13.2–52.7) | NA | NA | 15.2 (8.1–22.5) | 13.3 (7.5–20.5) | 15.2 (8.1–22.5) | 15.0 (10.4–26.0) |
Macrolide | 2.9 (1.8–3.4) | 5.4 | 2.8 (1.9–3.6) | 12.7 | 6.6 (2.6–14.5) | 7.7 (3.2–12.7) | NA | NA | NA | NA | 15.2 (8.1–22.5) | 13.3 (7.5–20.5) | NA | NA | NA | NA |